Catalysts in Regenerative Immunology and Rheumatology

Through the application of catalysts for immune engineering and cancer immune therapy.  

Regenerative immunology and rheumatology, using catalysts. Two distinct classifications of disease, grouped together on the same page, because of a common denominator. The Liver. Up until recently, it has been extremely difficult to regenerate liver cells, while simultaneously purging the body of toxins, and also limiting immune- overreaction, which causes inflammation.

Using only natural materials, we are controlling the signals that regulate immune cell response, by creating compounds that trigger immune response, in a way that exceeds the natural response that should naturally occur, but somehow didn’t, leading to the diseased state.

We are also clearing the bio-terrain of toxins that inhibit the natural flow of enzymes through cellular pathways, which then maintains the process we have restarted.

All things being equal, in terms of healthy lifestyle, there is no reason technically for the diseased state to return.

Timeous presentation of the patient, is of course a significant consideration.

Clinical trials are in the second year, after the development of the initial catalysts, and actual formulations of compounds will not be released until the end of the study.

Results are conclusively positive thus far with a success rate of 92%.


Get in touch

support@orchidhope.bio

+351 962 851 487

Monday - Friday 12:00 - 14:00

English